Mycoskin (Ciclopirox Olamine)

Ciclopirox olamine, the active ingredient in Mycoskin, is an antifungal presented as a topical formulation for skin application. It is used to treat fungal skin infections such as dermatophytosis, candidiasis, seborrheic dermatitis and other tinea conditions in adults and children.

GNH USA supplies Mycoskin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mycoskin is an antifungal agent that targets superficial fungal infections of the skin and scalp.

Dermatophytosis: reduces fungal growth and promotes clearance of skin lesions. Candidiasis: alleviates itching and erythema caused by Candida species. Seborrheic dermatitis: controls Malassezia‑related scaling and redness. Tinea infections: treats ringworm and related dermatophyte infections on various body sites.

Mycoskin may cause local skin reactions, most of which are mild and transient.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation after application. - Redness: localized erythema. - Dryness: skin may feel less moist. - Irritation: mild discomfort or stinging. - Scaling: slight flaking of the treated area.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash with swelling. - Angioedema: rapid swelling of face, lips or tongue. - Severe skin ulceration: breakdown of skin integrity. - Systemic hypersensitivity: rare generalized allergic reaction. - Bullous eruption: blister formation on the skin.

Before using Mycoskin, consider the following safety measures.

Avoid use on broken or inflamed skin: may increase irritation. Do not apply near eyes or mucous membranes: risk of severe discomfort. Discontinue if severe irritation or allergic reaction occurs: seek medical advice. Consult a healthcare professional before use on children under 2 years: safety not established. Store at room temperature: keep in the original container, protect from moisture and light.

Mycoskin may interact with other topical agents; monitor for combined effects.

Major Interactions (Avoid): - Concurrent use with other topical antifungals: may increase local irritation. - Combination with potent corticosteroid creams: can mask infection signs and delay healing.

Moderate Interactions (Monitor Closely): - Use with systemic antifungal therapy: potential additive antifungal effect. - Application over skin sensitizers (e.g., fragrances): may heighten dermatitis risk. - Use with alcohol‑based products: may affect drug absorption and increase dryness.